Eprobemide
From Wikipedia, the free encyclopedia
 |
|
| Clinical data | |
|---|---|
| Trade names | Befol (RU) |
| Routes of administration |
Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
|
|
| Synonyms | Befol |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C14H19ClN2O2 |
| Molar mass | 282.77 g/mol |
| 3D model (Jmol) | |
|
|
|
|
Eprobemide (INN) is a pharmaceutical drug that was used as an antidepressant in Russia (under the brand name Бефол/Befol).[1] It is a non-competitive reversible inhibitor of monoamine oxidase A[2][3] that exhibits selective action on serotonin deamination.[4] Eprobemide differs from moclobemide only in linker that connects morpholine fragment with chlorobenzamide—moclobemide has two carbon atoms while eprobemide has three. Its registration was cancelled on December 30, 2003.[5]
References[edit]
- ^ C.R. Ganellin, David J. Triggle (1996). Dictionary of Pharmacological Agents. 3. p. 811. ISBN 978-0412466304.
- ^ Gol'dina, O.A.; Moskvitina, T.A.; Gankina, E.M.; Kirkel', A.Z.; Kamyshanskaia, N.S.; Lopatina, K.I.; Sokolova, T.V.; Zagorevskiĭ, V.A.; Val'dman, A.V.; Gorkin, V.Z. (1991). "The action of befol and its derivatives on monoamine oxidase of different origins". Biulleten' eksperimental'noi biologii i meditsiny. 111 (3): 279–280. PMID 2054504.
- ^ Donskaya, N.S.; Antonkina, O.A.; Glukhan, E. N.; Smirnov, S. K. (2004-07-01). "Antidepressant Befol Synthesized Via Interaction of 4-Chloro-N-(3-chloropropyl)benzamide with Morpholine". Pharmaceutical Chemistry Journal. 0091-150X. Kluwer Academic Publishers-Plenum Publishers. 38 (7): 381–384. doi:10.1023/B:PHAC.0000048439.38383.5f.
- ^ Eprobemide, ChemIDplus
- ^ "Befol — 4DOKTOR.RU Drug Information Handbook" (in Russian). Retrieved 4 February 2014.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
